David B. Miklos

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Frederick L. Locke, David B. Miklos, Caron A. Jacobson et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

Medicine, Hematology, Oncology +8

Rituximab for steroid-refractory chronic graft-versus-host disease

Corey Cutler, David B. Miklos, Haesook T. Kim et al. · Blood · 2006 · 447 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +12

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

Jason R. Westin, Olalekan O. Oluwole, Marie José Kersten et al. · New England Journal of Medicine · 2023 · 410 citations · Full text

Medicine, Immunology, Oncology +17

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

David B. Miklos, Haesook T. Kim, Emmanuel Zorn et al. · Blood · 2003 · 161 citations · Full text

Life Sciences, Hematology, Immunology +15

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

Joseph H. Antin, Haesook T. Kim, Corey Cutler et al. · Blood · 2003 · 154 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16